Expert Opinion on Biological Therapy 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Biological therapies for the treatment of psoriasis in pediatrics
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - November 8, 2023 Category: Drugs & Pharmacology Authors: Mariam NikolaishviliVito Di Lerniaa Faculty of Medicine, Ivane Javakhishvili, Tbilisi State University, Tbilisi, Georgiab Dermatology Unit, Arcispedale Santa Maria Nuova, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy Source Type: research
What ’s new in the use of antibody-drug conjugates (ADCs) delivering pyrrolobenzodiazepine (PBD) DNA cross-linkers for cancer therapy?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 30, 2023 Category: Drugs & Pharmacology Authors: John A HartleyUCL Cancer Institute, London, UK Source Type: research
Antibody –drug conjugates targeting HER2-mutant or HER2-(non) amplified solid tumors: is HER2 an agnostic target?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 28, 2023 Category: Drugs & Pharmacology Authors: Lorenzo GuidiCarmine ValenzaDario TrapaniGiuseppe Curiglianoa Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italyb Department of Oncology and Hemato-Oncology, University of Milan, Source Type: research
Antibody-drug conjugates in oncology: insights into Current challenges
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 26, 2023 Category: Drugs & Pharmacology Authors: Ahmad Z. Al MeslamaniMohammad F. Bostanudina College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emiratesb AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates Source Type: research
Improving patient access to biosimilar tumor necrosis factor inhibitors in immune-mediated inflammatory disease: lessons learned from Norway
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 24, 2023 Category: Drugs & Pharmacology Authors: Guro L GollTore K Kviena Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norwayb Institute of Clinical Medicine, University of Oslo, Oslo, Norway Source Type: research
Antibody based therapeutics for autoimmune hemolytic anemia
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 24, 2023 Category: Drugs & Pharmacology Authors: Francesca CavallaroWilma BarcelliniBruno Fattizzoa Hematology Unit, Fondazione IRCCS Ca ’ Granda Ospedale Maggiore Policlinico, Milan, Italyb Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy Source Type: research
What future do biological therapies have in the treatment of gout?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 20, 2023 Category: Drugs & Pharmacology Authors: Lisa K StampAngelo Gaffoa Department of Medicine, University of Otago, Christchurch, New Zealandb Division of Rheumatology and Clinical Immunology, University of Alabama, Birmingham, USAc Birmingham VA Medical Center, Birmingham, USA Source Type: research
Bulevirtide and emerging drugs for the treatment of hepatitis D
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 19, 2023 Category: Drugs & Pharmacology Authors: Helen Y XuJamie O YangPhillip H ChenSteven-Huy B Hana Department of Medicine, UCLA Health, Los Angeles, CA, USAb Clinical Fellow in Gastroenterology, Department of Gastroenterology, UCLA Health, Los Angeles, CA, USAc Pfleger Liver Institute, UCLA Health, Source Type: research
Bispecific antibodies as monotherapy or in combinations for hematological malignancies: latest updates from the EHA 2023 annual meeting
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 19, 2023 Category: Drugs & Pharmacology Authors: Xingchen LiPeng ZhangHao SunLijie HanZhongxing JiangJifeng Yua Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Chinab Department of Orthopedics, Affiliated Hospital of Changchun University of Traditional Chines Source Type: research
Does pharmacological intervention prevent or delay the onset of psoriatic arthritis among psoriasis patients?
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 19, 2023 Category: Drugs & Pharmacology Authors: Marta LoredoIgnacio Bra ñaRubén Queiroa Rheumatology Division, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spainb Department of Translational Immunology, Biohealth Research Institute of the Principality of Asturias (ISPA), Oviedo, Spainc Source Type: research
Anacaulase-bcdb for the treatment of severe thermal burns
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 14, 2023 Category: Drugs & Pharmacology Authors: Yaron ShohamYuval KriegerJeremy Govermana Plastic and Reconstructive Surgery Department and Burn Unit, Soroka University Medical Center, Beer Sheba, Israelb Plastic Surgery Department and Burn Unit, Ben-Gurion University of the Negev Faculty of Health Sci Source Type: research
Managing adverse events of sacituzumab govitecan
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 6, 2023 Category: Drugs & Pharmacology Authors: Ilana SchlamPaolo TarantinoSara M. Tolaneya Department of Hematology and Oncology, Tufts Medical Center, Boston, MA, USAb Department of Medicine, Tufts University, Boston, MA, USAc Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USAd Breast On Source Type: research
An up-to-date review of approved and emerging antibody therapies for idiopathic pulmonary fibrosis
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - October 5, 2023 Category: Drugs & Pharmacology Authors: Jacopo SimonettiGiacomo SgallaLuca Richeldia Unita Operativa Complessa di Pneumologia, Dipartimento di Neuroscienze, Organi di Senso e Torace, Universit à Cattolica del Sacro Cuore, Rome, Italyb Unita Operativa Complessa di Pneumologia, Dipartimento di N Source Type: research
Oncolytic virotherapies for pediatric tumors
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - September 26, 2023 Category: Drugs & Pharmacology Authors: Evan G GrossMohammad A HamoDagoberto Estevez-OrdonezNicholas MB LaskayTravis J AtchleyJames M JohnstonJames M Markerta Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USAb Department of Neurosurgery, Heersink School of Me Source Type: research
Preparing for the third decade of biosimilars
Volume 23, Issue 8, July - December 2023 . (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - September 14, 2023 Category: Drugs & Pharmacology Authors: Ivo AbrahamGuest Editor; Center for Health Outcomes and PharmacoEconomic Research, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ, USA Source Type: research
